Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant ...
Shares of TransMedics (TMDX) are falling after Scorpion Capital revealed its short position on the company Friday. The ...
Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came ...
Philadelphia, Pennsylvania-- (Newsfile Corp. - January 10, 2025) - Kehoe Law Firm, P.C. is investigating potential securities class action claims on behalf of investors of TransMedics Group, Inc.
EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...
The report further alleges that TransMedics has been involved in kickbacks, billing fraud, unreported device failures, and ...
Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers ...
Dey, Aiyesha, Jonas Heese, Suraj Srinivasan, and Annelena Lobb. "Ginkgo Bioworks vs. Scorpion Capital: The Debate Over Related-Party Revenues." Harvard Business School Case 123-037, October 2022.
Daily Post Nigeria on MSN12d
“I can’t believe it” – Man thankful as FCT Police recover vehicle stolen on New Year’s eveOperatives of the Federal Capital Territory, FCT have recovered a stolen grey Toyota Corolla, registration number KWL 738 BB ...
NDAQ:TMDX) Kehoe Law Firm, P.C. Securities Investigation on Behalf of Investors of TransMedics Group Stock Following Critical Report - NASDAQ: TMDX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback